A study published in The Journal of Biological Chemistry in December 2015 brings new hope in the fight against the global obesity epidemic. Scientists at Weill Cornell Medicine in Qatar have found that low levels of a protein known as “SIRT1” are associated with an increase in adipose (fat) cells. SIRT1 plays a key role in regulating metabolism, and this new discovery points to its possible use in the development of new anti-obesity medication.
“With this knowledge, future research can look into developing drug therapies that mimic the function of SIRT1 to help improve metabolic function of people with obesity”, said Dr. Houri Abdesselem, one of the study’s authors. Worldwide obesity has doubled since 1980, according to the World Health Organization’s statistics; this new study may therefore bring hope to many who suffer from the condition.References